This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Sepofarsen
  • /
  • A Study to Evaluate Efficacy, Safety, Tolerability...
Clinical trial

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) (ILLUMINATE)

Read time: 1 mins
Last updated:10th Jan 2021
Status: Active, not recruiting
Identifier: NCT03913143
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest